4-(3-(trifluoromethoxy)phenoxy)benzenamine | 267416-85-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-(3-(trifluoromethoxy)phenoxy)benzenamine
• 英文别名: 4-(3-(Trifluoromethoxy)phenoxy)aniline；4-[3-(trifluoromethoxy)phenoxy]aniline
• CAS: 267416-85-3
• 化学式: C₁₃H₁₀F₃NO₂
• 分子量: 269.223
• InChiKey: YGMTVWZFRFZUDK-UHFFFAOYSA-N

物化性质

• 沸点：
  321.4±42.0 °C(Predicted)
• 密度：
  1.328±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.1
• 重原子数：
  19
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.08
• 拓扑面积：
  44.5
• 氢给体数：
  1
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  4-(3-(trifluoromethoxy)phenoxy)benzenamine 、 4,7-dichloro-N-ethylquinolinium triflate 在 三乙胺 作用下， 以 乙醇 为溶剂， 以85%的产率得到(E)-N-(7-chloro-1-ethylquinolin-4(1H)-ylidene)-4-(3-(trifluoromethoxy)phenoxy)aniline trifluoromethanesulfonate
  参考文献：
  名称：

  Quinolin-4(1H)-imines are Potent Antiplasmodial Drugs Targeting the Liver Stage of Malaria

  摘要：

  We present a novel series of quinolin-4(1H)-imines as dual-stage antiplasmodials, several-fold more active than primaquine in vitro against Plasmodium berghei liver stage. Among those, compounds 5g and 5k presented low nanomolar IC50 values. The compounds are metabolically stable and modulate several drug targets. These results emphasize the value of quinolin-4(1H)-imines as a new chemotype and their suitable properties for further drug development.

  DOI：

  10.1021/jm400246e
• 作为产物：
  描述：

  3-三氟甲氧基苯酚 在 铁粉 、 potassium carbonate 、 氯化铵 作用下， 以 四氢呋喃 、 水 、 乙腈 为溶剂， 反应 8.0h， 生成 4-(3-(trifluoromethoxy)phenoxy)benzenamine
  参考文献：
  名称：

  [EN] TRIAZOLES AS KV3 INHIBITORS
  [FR] TRIAZOLES EN TANT QU'INHIBITEURS DE KV3

  摘要：

  式(I)的化合物可用于调节Kv3.1、Kv3.2和Kv3.3通道，并在相关疾病的治疗或预防中具有用途。

  公开号：

  WO2013175215A1

文献信息

• Capreomycin derivatives and their use as antibacterials
  申请人：Lyssikatos P. Joseph

  公开号：US20060094644A1

  公开（公告）日：2006-05-04

  The present subject matter relates to phenylurea capreomycin derivatives, and to metabolites and pharmaceutically acceptable salts and solvates thereof. The compounds of the present subject matter are useful as antibacterial agents for treating bacterial infections and for treating disorders caused by bacterial infections. The present subject matter also relates to pharmaceutical compositions containing such compounds and to methods of treating bacterial infections by administering such compounds. The present subject matter also relates to methods of preparing such compounds.

  本发明涉及苯脲卡普霉素衍生物，以及它们的代谢物、药用可接受的盐和溶剂化物。本发明的化合物作为抗细菌剂用于治疗细菌感染和治疗由细菌感染引起的疾病。本发明还涉及包含这些化合物的药物组合物，以及通过施用这些化合物来治疗细菌感染的方法。本发明还涉及制备这些化合物的方法。
• CAPREOMYCIN DERIVATIVES AND THEIR USE AS ANTIBACTERIALS
  申请人：Lyssikatos Joseph P.

  公开号：US20090203585A1

  公开（公告）日：2009-08-13

  The present invention relates to phenylurea derivatives of capreomycin I, IIB, IIA, or IB, and metabolites and pharmaceutically acceptable salts and solvates thereof. The compounds of the present invention are useful as antibacterial agents for treating bacterial infections and for treating disorders caused by bacterial infections. The present invention also relates to pharmaceutical compositions containing such compounds and to methods of treating bacterial infections by administering such compounds. The present invention also relates to methods of preparing such compounds.

  本发明涉及卡普雷霉素I、IIB、IIA或IB的苯基脲衍生物，以及其代谢产物和药学上可接受的盐和溶剂。本发明的化合物可用作治疗细菌感染和由细菌感染引起的疾病的抗菌剂。本发明还涉及含有这种化合物的制药组合物以及通过给予这种化合物来治疗细菌感染的方法。本发明还涉及制备这种化合物的方法。
• PICOLINAMIDE DERIVATIVES AND PEST CONTROLLERS CONTAINING THE SAME AS THE ACTIVE INGREDIENT
  申请人：Meiji Seika Kaisha, Ltd.

  公开号：EP1134214A1

  公开（公告）日：2001-09-19

  Disclosed are novel compounds useful for the control of harmful organisms, harmful organism control agents using the same, and processes for producing the novel compounds. The useful novel compounds according to the present invention include compounds represented by formula (1). The compounds represented by formula (1) have potent activity against harmful organisms, and do not have phytotoxicity against agricultural and gardening plants, as objects to which the compounds of the present invention are applied for preventive and exterminating purposes, and human beings and beasts. wherein A represents a bond or an optionally substituted alkylene chain; R1 represents one or more groups, which may be the same or different, selected from the group consisting of a hydrogen atom, alkoxy, and haloalkoxy; R2 represents a hydrogen atom, benzyl, alkyl or alkanoyl, in which the groups other than the hydrogen atom may be substituted; and R3 represents a hydrogen atom, cycloalkyl, cycloalkenyl, aryl or a heterocyclic group, in which the groups other than the hydrogen atom may be substituted, excluding the case where R1 represents a hydrogen atom, A represents a bond or a methylene chain, and R3 represent phenyl or cyclohexyl, and the case where A represents an alkylene chain and R3 represents a hydrogen atom.

  本发明公开了用于控制有害生物的新型化合物、使用这些化合物的有害生物控制剂以及生产这些新型化合物的工艺。根据本发明，有用的新型化合物包括由式（1）代表的化合物。式（1）代表的化合物对有害生物具有强效活性，并且对农业和园艺植物没有植物毒性，而农业和园艺植物是本发明化合物用于预防和消灭的对象，人类和野兽也是本发明化合物的对象。 其中 A 代表键或任选取代的亚烷基链；R1 代表一个或多个基团，它们可以相同或不同，选自由氢原子、烷氧基和卤代烷氧基组成的组；R2 代表氢原子、苄基、烷基或烷酰基，其中氢原子以外的基团可以被取代；以及 R3 代表氢原子、环烷基、环烯基、芳基或杂环基，其中氢原子以外的基团可被取代，但不包括 R1 代表氢原子、A 代表键或亚甲基链、R3 代表苯基或环己基的情况，以及 A 代表亚烷基链、R3 代表氢原子的情况。
• HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF EPILEPSY
  申请人：OTSUKA PHARMACEUTICAL CO., LTD.

  公开号：US20210403456A1

  公开（公告）日：2021-12-30

  The present invention provides a novel heterocyclic compound represented by Formula [I] and a salt thereof: wherein the symbols are as defined in the specification, which is useful for treating, preventing and/or diagnosing seizure and the like in disease involving epileptic seizure or convulsive seizure (including multiple drug resistant seizure, refractory seizure, acute symptomatic seizure, febrile seizure and status epilepticus), as well as a medical use therefor.
• US7183278B1
  申请人：——

  公开号：US7183278B1

  公开（公告）日：2007-02-27